Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance

In This Article: Eli Lilly (LLY) reported first quarter earnings beating Wall Street's expectations Thursday on the top and bottom lines, but GLP-1 sales weren't as strong as expected. Lilly reported adjusted earnings per share of $3.34 compared to consensus of $3.10. Revenue came in at $12.73…